Recent Updates
Recently added Catalysts

Deep brain stimulation

Phase 3

Cervical Dystonia | Unknown | Neurology |Medtronic plc.|Last Updated: Feb 19, 2018

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindACTIVE_CONTROLLED
Total Trials1
Total Enrollment63
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT00148889Double-blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients With Medically Refractory Primary Cervical DystoniaPHASE3 COMPLETED 63Jul 1, 2005Apr 1, 2008Feb 19, 201810 Austria, Germany
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Toronto Western Spasmodic Torticollis Scale (TWSTRS) at 3 months following surgery (comparison between placebo and control group)
3 months
Secondary Endpoints
side-effects, quality of life, depression, pain, long-term efficacy
5 years
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingTRIPLE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
2SHAM_COMPARATORSham-stimulation
1ACTIVE_COMPARATORActive GPI-DBS
Interventions
NameTypeDescription
Deep brain stimulation (DBS)DEVICEBilateral pallidal stimulation with an implanted DBS device
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — N/A
SexALL
Healthy VolunteersNo
Study Sites10

Inclusion Criteria: * Primary cervical dystonia * Disease duration 3 years or longer * Adult patient (18 years or older) * TWSTRS severity score 15 or more * Non-response to Botulinum Toxin * Non-response to oral antidystonic medication * Informed consent Exclusion Criteria: * Dementia (Mattis De...

Countries:AustriaGermany
Unlock Eligibility Criteria